关注
Professor David P. Finn
Professor David P. Finn
Pharmacology, Centre for Pain Research, National University of Ireland Galway
在 nuigalway.ie 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The effect of pain on cognitive function: a review of clinical and preclinical research
O Moriarty, BE McGuire, DP Finn
Progress in neurobiology 93 (3), 385-404, 2011
11042011
Stress-induced analgesia
RK Butler, DP Finn
Progress in neurobiology 88 (3), 184-202, 2009
7022009
Stress-induced hyperalgesia
EM Jennings, BN Okine, M Roche, DP Finn
Progress in neurobiology 121, 1-18, 2014
2742014
The cannabinoid system and pain
SG Woodhams, V Chapman, DP Finn, AG Hohmann, V Neugebauer
Neuropharmacology 124, 105-120, 2017
2492017
Psychological stress in early life as a predisposing factor for the development of chronic pain: clinical and preclinical evidence and neurobiological mechanisms
NN Burke, DP Finn, BE McGuire, M Roche
Journal of neuroscience research 95 (6), 1257-1270, 2017
2342017
European Pain Federation (EFIC) position paper on appropriate use of cannabisbased medicines and medical cannabis for chronic pain management
W Häuser, DP Finn, E Kalso, N KrcevskiSkvarc, HG Kress, B Morlion, ...
European Journal of Pain 22 (9), 1547-1564, 2018
1932018
Alterations in the endocannabinoid system in the rat valproic acid model of autism
DM Kerr, L Downey, M Conboy, DP Finn, M Roche
Behavioural brain research 249, 124-132, 2013
1782013
Cannabinoids and pain: sites and mechanisms of action
K Starowicz, DP Finn
Advances in Pharmacology 80, 437-475, 2017
1532017
Minocycline modulates neuropathic pain behaviour and cortical M1–M2 microglial gene expression in a rat model of depression
NN Burke, DM Kerr, O Moriarty, DP Finn, M Roche
Brain, behavior, and immunity 42, 147-156, 2014
1532014
Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat
S Walsh, DP Finn, E Dowd
Neuroscience 175, 251-261, 2011
1532011
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats
DP Finn, MD Jhaveri, SRG Beckett, CH Roe, DA Kendall, CA Marsden, ...
Neuropharmacology 45 (5), 594-604, 2003
1532003
Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials
E Fisher, RA Moore, AE Fogarty, DP Finn, NB Finnerup, I Gilron, ...
Pain 162, S45-S66, 2021
1142021
Cognition and pain
O Moriarty, DP Finn
Current opinion in supportive and palliative care 8 (2), 130-136, 2014
1092014
Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate
K Rea, M Roche, DP Finn
British journal of pharmacology 152 (5), 633-648, 2007
1042007
The effect of CB1 receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats
M Roche, E O'Connor, C Diskin, DP Finn
European Journal of Neuroscience 26 (9), 2643-2653, 2007
1032007
Experimental pain processing in individuals with cognitive impairment: current state of the science
R Defrin, M Amanzio, M De Tommaso, V Dimova, S Filipovic, DP Finn, ...
Pain 156 (8), 1396-1408, 2015
1022015
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease
RM Concannon, BN Okine, DP Finn, E Dowd
Experimental neurology 269, 133-141, 2015
1022015
Clinical correlates of stress-induced analgesia: evidence from pharmacological studies
GK Ford, DP Finn
Pain 140 (1), 3-7, 2008
972008
Implantation of hyaluronic acid hydrogel prevents the pain phenotype in a rat model of intervertebral disc injury
IL Mohd Isa, SA Abbah, M Kilcoyne, D Sakai, P Dockery, DP Finn, ...
Science Advances 4 (4), eaaq0597, 2018
952018
Cognitive impairment in patients with chronic neuropathic or radicular pain: an interaction of pain and age
O Moriarty, N Ruane, D O'Gorman, CH Maharaj, C Mitchell, KM Sarma, ...
Frontiers in behavioral neuroscience 11, 100, 2017
952017
系统目前无法执行此操作,请稍后再试。
文章 1–20